RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
SomaLogic of Boulder, Colorado capped its $200 million funding round, anchored by China’s iCarbonX and joined by Nan Fung Life Sciences and Madryn Asset Management. SomaLogic measures the levels of human proteins in an individual as a tool for managing their health and wellness. The company’s SOMAscan® technology, which currently measures 5,000 proteins per sample, has analyzed more than 150,000 samples across more than 50 diseases or conditions. It plans to complete another 1 million samples by the end of 2020.
